Clinical Trial Update: Safety and Efficacy of Talampanel in Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the safety and efficacy of Talampanel in Glioblastoma. The update reports outcomes from the Phase 2 study conducted by Teva Brand…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Talampanel (talampanel)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED